Cubist to Present at August Investor Conference

Business Wire

LEXINGTON, Mass.--(BUSINESS WIRE)--

Cubist Pharmaceuticals, Inc. (CBST) today announced that company management will discuss Cubist’s business activities and financial outlook at investor conferences during August 2013.

On Wednesday, August 6, Robert Perez, Cubist President and COO, and Michael Tomsicek, Cubist SVP and Chief Financial Officer, will host one-on-one meetings at the Jefferies 2014 Boston Healthcare Summit at the Boston Harbor Hotel in Boston, Massachusetts. Eileen C. McIntyre, Cubist VP Investor Relations will be joining as well. These meetings will not be webcast.

About Cubist
Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address significant unmet medical needs in the acute care environment. Cubist is headquartered in Lexington, Mass. Additional information can be found at Cubist’s website.

Contact:
Cubist Pharmaceuticals, Inc.
INVESTORS:
Eileen C. McIntyre, 781-860-8533
Vice President, Investor Relations
eileen.mcintyre@cubist.com
or
MEDIA:
Julie DiCarlo, 781-860-8063
Senior Director, Corporate Communications
julie.dicarlo@cubist.com

View Comments (0)